chloroform has been researched along with bromobenzene in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (28.57) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crippen, GM; Ghose, AK | 1 |
| Caron, G; Ermondi, G | 1 |
| Abellán Guillén, A; Cordeiro, MN; Garrido Escudero, A; Morales Helguera, A; Pérez-Garrido, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Brandt, I; Brittebo, EB; Eriksson, C | 1 |
| Hook, JB; Smith, JH | 1 |
| Dent, JG; Leonard, TB | 1 |
| Hook, JB; Newton, JF; Rush, GF; Smith, JH | 1 |
| Gandolfi, AJ; Lind, RC | 2 |
| Hennig, GE; Manautou, JE; Silva, VM; Whiteley, HE | 1 |
| Ali, S; Pawa, S | 1 |
| Bellomo, A; Brovetto, M; Gonzalez, D; Seoane, G; Vitelio, C | 1 |
2 review(s) available for chloroform and bromobenzene
| Article | Year |
|---|---|
Biochemical mechanisms of nephrotoxicity.
Topics: Acetaminophen; Aminoglycosides; Animals; Biotransformation; Bromobenzenes; Cephaloridine; Chloroform; Female; Kidney; Kidney Diseases; Liver; Male; Organ Specificity | 1985 |
Chemically induced nephrotoxicity: role of metabolic activation.
Topics: Acetaminophen; Animals; Antifungal Agents; Antinematodal Agents; Biotransformation; Bromobenzenes; Butadienes; Carbon Tetrachloride; Cephaloridine; Chloroform; Ethylene Dibromide; Female; Humans; Inactivation, Metabolic; Kidney; Kidney Diseases; Lethal Dose 50; Male; Organophosphates; Propane; Rats; Terpenes | 1984 |
12 other study(ies) available for chloroform and bromobenzene
| Article | Year |
|---|---|
Use of physicochemical parameters in distance geometry and related three-dimensional quantitative structure-activity relationships: a demonstration using Escherichia coli dihydrofolate reductase inhibitors.
Topics: Binding Sites; Escherichia coli; Folic Acid Antagonists; Models, Molecular; Protein Conformation; Structure-Activity Relationship | 1985 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
Topics: beta-Cyclodextrins; Hydrophobic and Hydrophilic Interactions; Organic Chemicals; Quantitative Structure-Activity Relationship | 2009 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Metabolic activation of halogenated hydrocarbons in the conjunctival epithelium and excretory ducts of the intraorbital lacrimal gland in mice.
Topics: Animals; Autoradiography; Biotransformation; Bromobenzenes; Carbon Tetrachloride; Chloroform; Conjunctiva; Epithelium; Ethylene Dibromide; Eyelids; Female; Hydrocarbons, Halogenated; In Vitro Techniques; Lacrimal Apparatus; Male; Mice; Mice, Inbred C57BL; Rats; Rats, Inbred Strains | 1991 |
Effects of H2 receptor antagonists on the hepatotoxicity of various chemicals.
Topics: 1-Propanol; Acetaminophen; Animals; Bromobenzenes; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Chloroform; Cimetidine; Drug Antagonism; Drug Synergism; Histamine H2 Antagonists; Imidazoles; Liver; Male; Propanols; Pyrimidinones; Ranitidine; Rats; Rats, Inbred F344 | 1984 |
Late dimethyl sulfoxide administration provides a protective action against chemically induced injury in both the liver and the kidney.
Topics: Administration, Inhalation; Administration, Oral; Alanine Transaminase; Allyl Compounds; Animals; Biomarkers; Biotransformation; Bromobenzenes; Chemical and Drug Induced Liver Injury; Chloroform; Dimethyl Sulfoxide; Drug Administration Schedule; Glutathione; Guinea Pigs; Halothane; Kidney; Kidney Tubular Necrosis, Acute; Liver; Male; Necrosis; Rats; Rats, Sprague-Dawley; Sulfides | 1997 |
Repeated dosing with the peroxisome proliferator clofibrate decreases the toxicity of model hepatotoxic agents in male mice.
Topics: Administration, Oral; Animals; Anticholesteremic Agents; Blood Urea Nitrogen; Bromobenzenes; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Chloroform; Clofibrate; Injections, Intraperitoneal; Kidney; L-Iditol 2-Dehydrogenase; Liver; Male; Mice; Mice, Inbred C57BL; Microbodies; Sulfhydryl Compounds | 1998 |
Hepatoprotection by dimethyl sulfoxide. II. Characterization of optimal dose and the latest time of administration for effective protection against chloroform and bromobenzene induced injury.
Topics: Animals; Bromobenzenes; Chemical and Drug Induced Liver Injury; Chloroform; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Free Radical Scavengers; Liver Diseases; Male; Rats; Rats, Sprague-Dawley; Time Factors | 1999 |
Liver necrosis and fulminant hepatic failure in rats: protection by oxyanionic form of tungsten.
Topics: Acetaminophen; Alkaline Phosphatase; Allopurinol; Animals; Bromobenzenes; Carbon Tetrachloride Poisoning; Chloroform; Dimethyl Sulfoxide; Female; Lethal Dose 50; Liver; Liver Failure; Necrosis; Oxidative Stress; Rats; Rats, Wistar; Thioacetamide; Transaminases; Tungsten Compounds | 2004 |
Concise chemoenzymatic synthesis of epi-inositol.
Topics: Bromobenzenes; Catalysis; Chloroform; Epoxy Compounds; Hydrolysis; Inositol; Models, Chemical; Oxygen; Oxygenases; Stereoisomerism; Substrate Specificity | 2004 |